EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis

Christian Trapp iD, Daniel M Aebersold, Claus Belka, Jozefina Casuscelli, Louise Emmett, Chukwuka Eze, Stefano Fanti, Andrea Farolfi, Wolfgang Fendler, Anca-Ligia Grosu, Matthias Guckenberger, George Hruby und 14 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2024

DOI: 10.1007/s00259-024-06802-x ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Christian Trapp und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. christian.trapp@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Pelvis, Propensity Score. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Klinikum der Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Despite growing evidence for bilateral pelvic radiotherapy (whole pelvis RT, WPRT) there is almost no data on unilateral RT (hemi pelvis RT, HPRT) in patients with nodal recurrent prostate cancer after prostatectomy. Nevertheless, in clinical practice HPRT is sometimes used with the intention to reduce side effects compared to WPRT. Prostate-specific membrane antigen positron emission tomography / computed tomography (PSMA-PET/CT) is currently the best imaging modality in this clinical situation. This analysis compares PSMA-PET/CT based WPRT and HPRT.

Methods

A propensity score matching was performed in a multi-institutional retrospective dataset of 273 patients treated with pelvic RT due to nodal recurrence (214 WPRT, 59 HPRT). In total, 102 patients (51 in each group) were included in the final analysis. Biochemical recurrence-free survival (BRFS) defined as prostate specific antigen (PSA) < post-RT nadir + 0.2ng/ml, metastasis-free survival (MFS) and nodal recurrence-free survival (NRFS) were calculated using the Kaplan-Meier method and compared using the log rank test.

Results

Median follow-up was 29 months. After propensity matching, both groups were mostly well balanced. However, in the WPRT group there were still significantly more patients with additional local recurrences and biochemical persistence after prostatectomy. There were no significant differences between both groups in BRFS ( p = .97), MFS ( p = .43) and NRFS ( p = .43). After two years, BRFS, MFS and NRFS were 61%, 86% and 88% in the WPRT group and 57%, 90% and 82% in the HPRT group, respectively. Application of a boost to lymph node metastases, a higher RT dose to the lymphatic pathways (> 50 Gy EQD2 α/β=1.5 Gy ) and concomitant androgen deprivation therapy (ADT) were significantly associated with longer BRFS in uni- and multivariate analysis.

Conclusions

Overall, this analysis presents the outcome of HPRT in nodal recurrent prostate cancer patients and shows that it can result in a similar oncologic outcome compared to WPRT. Nevertheless, patients in the WPRT may have been at a higher risk for progression due to some persistent imbalances between the groups. Therefore, further research should prospectively evaluate which subgroups of patients are suitable for HPRT and if HPRT leads to a clinically significant reduction in toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyProstatic NeoplasmsPelvisPropensity ScoreGlutamate Carboxypeptidase IIHumansMaleRetrospective StudiesAgedMiddle AgedPositron Emission Tomography Computed TomographyAntigens, SurfaceLymphatic MetastasisRecurrenceNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Hemi pelvisNodal recurrencePSMA PET/CTProstate cancerRadiotherapyWhole pelvis

Substanzen

Glutamate Carboxypeptidase IIFOLH1 protein, humanAntigens, Surface

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. christian.trapp@med.uni-muenchen.de.
  • Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
  • Department of Urology, University Hospital, LMU Munich, Munich, Germany.
  • Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia.

ORCID-Profile: Christian Trapp

Förderung

  • Klinikum der Universität München

Zitieren

APA

Trapp, C., Aebersold, D. M., Belka, C., Casuscelli, J., Emmett, L., Eze, C., Fanti, S., Farolfi, A., Fendler, W., Grosu, A. L., Guckenberger, M., Hruby, G., Kirste, S., Koerber, S. A., Kroeze, S., Peeken, J. C., Rogowski, P., Scharl, S., Shelan, M., …, & Schmidt-Hegemann, N. S. (2024). Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06802-x

Vancouver

Trapp C, Aebersold DM, Belka C, Casuscelli J, Emmett L, Eze C, et al. Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06802-x

BibTeX
@article{Trapp2024,
  author = {Trapp, Christian and Aebersold, Daniel M and Belka, Claus and Casuscelli, Jozefina and Emmett, Louise and Eze, Chukwuka and Fanti, Stefano and Farolfi, Andrea and Fendler, Wolfgang and Grosu, Anca-Ligia and Guckenberger, Matthias and Hruby, George and Kirste, Simon and Koerber, Stefan A and Kroeze, Stephanie and Peeken, Jan C and Rogowski, Paul and Scharl, Sophia and Shelan, Mohamed and Spohn, Simon K B and Strouthos, Iosif and Unterrainer, Lena and Vogel, Marco and Wiegel, Thomas and Zamboglou, Constantinos and Schmidt-Hegemann, Nina-Sophie},
  title = {Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  doi = {10.1007/s00259-024-06802-x}
}
Kostenlos starten →